These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 36609964)

  • 1. Upregulation of PD-L1 by SARS-CoV-2 promotes immune evasion.
    Huang HC; Wang SH; Fang GC; Chou WC; Liao CC; Sun CP; Jan JT; Ma HH; Ko HY; Ko YA; Chiang MT; Liang JJ; Kuo CT; Lee TA; Morales-Scheihing D; Shen CY; Chen SY; McCullough LD; Cui L; Wernig G; Tao MH; Lin YL; Chang YM; Wang SP; Lai YJ; Li CW
    J Med Virol; 2023 Feb; 95(2):e28478. PubMed ID: 36609964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How do deer respiratory epithelial cells weather the initial storm of SARS-CoV-2 WA1/2020 strain?
    Sarlo Davila KM; Nelli RK; Phadke KS; Ruden RM; Sang Y; Bellaire BH; Gimenez-Lirola LG; Miller LC
    Microbiol Spectr; 2024 Feb; 12(2):e0252423. PubMed ID: 38189329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 infection: The role of PD-1/PD-L1 and CTLA-4 axis.
    Aghbash PS; Eslami N; Shamekh A; Entezari-Maleki T; Baghi HB
    Life Sci; 2021 Apr; 270():119124. PubMed ID: 33508291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shikonin-mediated PD-L1 degradation suppresses immune evasion in pancreatic cancer by inhibiting NF-κB/STAT3 and NF-κB/CSN5 signaling pathways.
    Ruan Z; Liang M; Shang L; Lai M; Deng X; Su X
    Pancreatology; 2021 Apr; 21(3):630-641. PubMed ID: 33707115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PD-L1 Dysregulation in COVID-19 Patients.
    Sabbatino F; Conti V; Franci G; Sellitto C; Manzo V; Pagliano P; De Bellis E; Masullo A; Salzano FA; Caputo A; Peluso I; Zeppa P; Scognamiglio G; Greco G; Zannella C; Ciccarelli M; Cicala C; Vecchione C; Filippelli A; Pepe S
    Front Immunol; 2021; 12():695242. PubMed ID: 34163490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of NF-κB and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2.
    Su CM; Wang L; Yoo D
    Sci Rep; 2021 Jun; 11(1):13464. PubMed ID: 34188167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of PD-1 Expression and High sPD-L1 Levels Associated with COVID-19 Severity.
    Beserra DR; Alberca RW; Branco ACCC; de Mendonça Oliveira L; de Souza Andrade MM; Gozzi-Silva SC; Teixeira FME; Yendo TM; da Silva Duarte AJ; Sato MN
    J Immunol Res; 2022; 2022():9764002. PubMed ID: 35971391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD-L1 Overexpression in the Lungs of Subjects Who Died from COVID-19: Are We on the Way to Understanding the Immune System Exhaustion Induced by SARS-CoV-2?
    Ronchi A; Marino FZ; Carraturo E; La Mantia E; Campobasso CP; De Micco F; Mascolo P; Municinò M; Mucininò E; Vestini F; Pinto O; Moccia M; De Stefano N; Nappi O; Sementa C; Zotti G; Pianese L; Giordano C; Fico A; Franco R
    Crit Rev Eukaryot Gene Expr; 2022; 32(3):9-20. PubMed ID: 35695606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitination of SARS-CoV-2 NSP6 and ORF7a Facilitates NF-κB Activation.
    Nishitsuji H; Iwahori S; Ohmori M; Shimotohno K; Murata T
    mBio; 2022 Aug; 13(4):e0097122. PubMed ID: 35856559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokines, soluble PD-L1, and immune cell hyporesponsiveness are distinct features of SARS-CoV-2 critical illness.
    Morrell ED; Bhatraju PK; Sathe NA; Lawson J; Mabrey L; Holton SE; Presnell SR; Wiedeman A; Acosta-Vega C; Mitchem MA; Liu T; Chai XY; Sahi S; Brager C; Orlov M; Sakr SS; Sader A; Lum DM; Koetje N; Garay A; Barnes E; Cromer G; Bray MK; Pipavath S; Fink SL; Evans L; Long SA; West TE; Wurfel MM; Mikacenic C
    Am J Physiol Lung Cell Mol Physiol; 2022 Jul; 323(1):L14-L26. PubMed ID: 35608267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PD-1 blockade counteracts post-COVID-19 immune abnormalities and stimulates the anti-SARS-CoV-2 immune response.
    Loretelli C; Abdelsalam A; D'Addio F; Ben Nasr M; Assi E; Usuelli V; Maestroni A; Seelam AJ; Ippolito E; Di Maggio S; Loreggian L; Radovanovic D; Vanetti C; Yang J; El Essawy B; Rossi A; Pastore I; Montefusco L; Lunati ME; Bolla AM; Biasin M; Antinori S; Santus P; Riva A; Zuccotti GV; Galli M; Rusconi S; Fiorina P
    JCI Insight; 2021 Dec; 6(24):. PubMed ID: 34784300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case Report: A Peculiar Case of Inflammatory Colitis After SARS-CoV-2 Infection.
    Rutigliani M; Bozzo M; Barberis A; Greppi M; Anelli E; Castellaro L; Bonsignore A; Azzinnaro A; Pesce S; Filauro M; Rollandi GA; Castagnola P; Candiani S; Marcenaro E
    Front Immunol; 2022; 13():849140. PubMed ID: 35222440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTRF/Cavin-1 as a Novel RNA-Binding Protein Expedites the NF-κB/PD-L1 Axis by Stabilizing lncRNA NEAT1, Contributing to Tumorigenesis and Immune Evasion in Glioblastoma.
    Yi K; Cui X; Liu X; Wang Y; Zhao J; Yang S; Xu C; Yang E; Xiao M; Hong B; Fang C; Kang C; Tan Y; Wang Q
    Front Immunol; 2021; 12():802795. PubMed ID: 35069587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4
    Popescu I; Snyder ME; Iasella CJ; Hannan SJ; Koshy R; Burke R; Das A; Brown MJ; Lyons EJ; Lieber SC; Chen X; Sembrat JC; Bhatt P; Deng E; An X; Linstrum K; Kitsios G; Konstantinidis I; Saul M; Kass DJ; Alder JK; Chen BB; Lendermon EA; Kilaru S; Johnson B; Pilewski JM; Kiss JE; Wells AH; Morris A; McVerry BJ; McMahon DK; Triulzi DJ; Chen K; Sanchez PG; McDyer JF
    Am J Respir Crit Care Med; 2022 Jun; 205(12):1403-1418. PubMed ID: 35348444
    [No Abstract]   [Full Text] [Related]  

  • 15. Improving the Understanding of the Immunopathogenesis of Lymphopenia as a Correlate of SARS-CoV-2 Infection Risk and Disease Progression in African Patients: Protocol for a Cross-sectional Study.
    Iwalokun BA; Olalekan A; Adenipekun E; Ojo O; Iwalokun SO; Mutiu B; Orija O; Adegbola R; Salako B; Akinloye O
    JMIR Res Protoc; 2021 Mar; 10(3):e21242. PubMed ID: 33621190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HOTAIR Up-Regulation Activates NF-κB to Induce Immunoescape in Gliomas.
    Wang Y; Yi K; Liu X; Tan Y; Jin W; Li Y; Zhou J; Wang H; Kang C
    Front Immunol; 2021; 12():785463. PubMed ID: 34887871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of programmed death ligand 1 expression by interferon-γ and tumour necrosis factor-α in canine tumour cell lines.
    Owaki R; Deguchi T; Konnai S; Maekawa N; Okagawa T; Hosoya K; Kim S; Sunaga T; Okumura M
    Vet Comp Oncol; 2023 Jun; 21(2):279-290. PubMed ID: 36802270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Nsp14 protein associates with IMPDH2 and activates NF-κB signaling.
    Li TW; Kenney AD; Park JG; Fiches GN; Liu H; Zhou D; Biswas A; Zhao W; Que J; Santoso N; Martinez-Sobrido L; Yount JS; Zhu J
    Front Immunol; 2022; 13():1007089. PubMed ID: 36177032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D can reduce severity in COVID-19 through regulation of PD-L1.
    Aygun H
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Apr; 395(4):487-494. PubMed ID: 35099571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory cytokines IL-17 and TNF-α up-regulate PD-L1 expression in human prostate and colon cancer cells.
    Wang X; Yang L; Huang F; Zhang Q; Liu S; Ma L; You Z
    Immunol Lett; 2017 Apr; 184():7-14. PubMed ID: 28223102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.